Progyny Inc (PGNY)
32.80
+0.26
(+0.80%)
USD |
NASDAQ |
Apr 30, 11:39
Progyny Enterprise Value: 2.769B for April 29, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 29, 2024 | 2.769B |
| April 26, 2024 | 2.721B |
| April 25, 2024 | 2.765B |
| April 24, 2024 | 2.775B |
| April 23, 2024 | 2.755B |
| April 22, 2024 | 2.819B |
| April 19, 2024 | 2.784B |
| April 18, 2024 | 2.705B |
| April 17, 2024 | 2.789B |
| April 16, 2024 | 2.851B |
| April 15, 2024 | 2.892B |
| April 12, 2024 | 2.929B |
| April 11, 2024 | 3.003B |
| April 10, 2024 | 2.990B |
| April 09, 2024 | 3.098B |
| April 08, 2024 | 3.087B |
| April 05, 2024 | 3.044B |
| April 04, 2024 | 3.055B |
| April 03, 2024 | 3.079B |
| April 02, 2024 | 3.071B |
| April 01, 2024 | 3.152B |
| March 28, 2024 | 3.310B |
| March 27, 2024 | 3.295B |
| March 26, 2024 | 3.203B |
| March 25, 2024 | 3.199B |
| Date | Value |
|---|---|
| March 22, 2024 | 3.223B |
| March 21, 2024 | 3.204B |
| March 20, 2024 | 3.157B |
| March 19, 2024 | 3.131B |
| March 18, 2024 | 3.133B |
| March 15, 2024 | 3.023B |
| March 14, 2024 | 3.045B |
| March 13, 2024 | 3.169B |
| March 12, 2024 | 3.108B |
| March 11, 2024 | 3.098B |
| March 08, 2024 | 3.054B |
| March 07, 2024 | 2.964B |
| March 06, 2024 | 2.874B |
| March 05, 2024 | 2.958B |
| March 04, 2024 | 3.053B |
| March 01, 2024 | 3.105B |
| February 29, 2024 | 3.153B |
| February 28, 2024 | 2.973B |
| February 27, 2024 | 3.565B |
| February 26, 2024 | 3.476B |
| February 23, 2024 | 3.361B |
| February 22, 2024 | 3.269B |
| February 21, 2024 | 3.518B |
| February 20, 2024 | 3.527B |
| February 16, 2024 | 3.564B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.308B
Minimum
Apr 02 2020
5.914B
Maximum
Nov 08 2021
3.281B
Average
3.181B
Median
Feb 22 2022
Enterprise Value Benchmarks
| Delcath Systems Inc | 110.23M |
| Star Equity Holdings Inc | 12.60M |
| Exact Sciences Corp | 12.26B |
| Illumina Inc | 20.25B |
| CytoSorbents Corp | 34.67M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 13.47M |
| Revenue (Quarterly) | 269.94M |
| Total Expenses (Quarterly) | 256.14M |
| EPS Diluted (Quarterly) | 0.13 |
| Gross Profit Margin (Quarterly) | 21.08% |
| Profit Margin (Quarterly) | 4.99% |
| Earnings Yield | 1.89% |
| Operating Earnings Yield | 1.88% |
| Normalized Earnings Yield | 1.890 |